Prognostic implication of a focal lesion of bone marrow in diffuse large B cell lymphosarcoma

被引:0
|
作者
Magomedova, AU [1 ]
Kremenetskaya, AM [1 ]
Vorobyev, IA [1 ]
Kravchenko, SK [1 ]
Kaplanskaya, IB [1 ]
Samoilova, RS [1 ]
Gemdzhyan, EG [1 ]
Vorobyev, AI [1 ]
机构
[1] Russian Acad Med Sci, State Res Ctr, Moscow, Russia
来源
TERAPEVTICHESKII ARKHIV | 2004年 / 76卷 / 07期
关键词
diffuse B large cell lymphosarcoma; mature cell lesion of the bone marrow; CHOP; survival;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study prognostic implications of a focal mature cell lesion of the bone marrow (BM) in patients with diffuse large B cell lymphosarcoma (DBLCL). Material and methods. 54 patients with histologically confirmed DBLCL were given first-line CHOP and CHOP-like courses from 1996 to 2003. B-cell nature of the tumor was confirmed immunohistochemically, immunophenotypically and with flow fluorimetry. Results. In debute of the disease 16 patients had local involvement of the lymph organs (stage I-II by Enn-Arbor), 21 patients - generalized disease (stage III-IV) and 17 patients - involvement of non-lymphatic organs. Overall 3-year survival in first-line therapy in mature cell lesion of BM was 23%, without it - 0%. One-year event-free survival was 34 and 0%, respectively. Conclusion. The presence of a focal mature cell lesion of BM in DBLCL patients influences the prognosis. Regarding high frequency of transformation of mature cell lymphoproliferative diseases in DBLCL, focal lesion of BM is an indirect sign of a secondary nature of the disease.
引用
收藏
页码:60 / 63
页数:4
相关论文
共 50 条
  • [1] International prognostic index in diffuse B large cell lymphosarcoma
    Magomedova, A. U.
    Vorobyev, A. I.
    [J]. TERAPEVTICHESKII ARKHIV, 2008, 80 (03): : 71 - 76
  • [2] Treatment of diffuse large B-cell lymphosarcoma with involvement of bone marrow in an old female patient
    Zamyatina, V., I
    Kravchenko, S. K.
    Gilyazitdinova, E. A.
    Mag-omedova, A. U.
    Vorobyev, I. A.
    Gotman, L. N.
    Kaplan-skaya, I. B.
    Keselman, S. A.
    Obukhova, T. N.
    Sakhibov, Ya. D.
    Shevelev, A. A.
    Kremenetskaya, A. M.
    [J]. TERAPEVTICHESKII ARKHIV, 2008, 80 (07): : 54 - 57
  • [3] Prognostic significance of bone marrow fibrosis in diffuse large B-cell lymphoma
    Cetintepe, Tugba
    Ozkan, Gamze
    Kucukzeybek, Betul Polat
    Cetintepe, Lutfi
    Unal, Demet Kiper
    Solmaz, Serife
    Aygun, Kemal
    Acar, Alev Garip
    Bener, Sadi
    Calli, Aylin Orgen
    Payzin, Kadriye Bahriye
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (03) : 523 - 530
  • [4] Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma
    Han, Xiao
    Ruan, Jing
    Zhang, Wei
    Zhou, Daobin
    Xu, Dongsheng
    Pei, Qiang
    Ouyang, Mingqi
    Zuo, Mengxuan
    [J]. ONCOTARGET, 2017, 8 (29) : 47790 - 47800
  • [5] Diffuse large B-cell lymphoma in the primary bone marrow
    Hu, Y.
    Chen, S. L.
    Huang, Z. X.
    Gao, W.
    An, N.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 6247 - 6250
  • [6] Diffuse large B cell lymphoma of bone marrow at initial presentation
    Kajiura, Dai
    Yamashita, Yoriko
    Mori, Naoyoshi
    [J]. MODERN PATHOLOGY, 2006, 19 : 116 - 116
  • [7] Biological Features and Prognostic Impact of Bone Marrow Infiltration in Patients with Diffuse Large B-cell Lymphoma
    Alonso-Alvarez, Sara
    Alcoceba, Miguel
    Garcia-Alvarez, Maria
    Blanco, Oscar
    Rodriguez, Marta
    Baile, Monica
    Carlos Caballero, Juan
    Davila, Julio
    Belen Vidriales, Maria
    Esteban, Carmen
    Arias, Piedad
    Diaz, Luis G.
    Tamayo, Pilar
    Dolores Caballero, Maria
    Gutierrez, Norma C.
    Gonzalez, Marcos
    Martin, Alejandro
    [J]. CANCERS, 2020, 12 (02)
  • [8] Primary diffuse large B-cell lymphosarcoma of the spleen
    Magomedova, A. U.
    Kravchenko, S. K.
    Kremenetskaya, A. M.
    Kaplanskaya, I. B.
    Zybunova, E. E.
    Samoilova, R. S.
    Vorobyev, I. A.
    Obukhova, T. N.
    Byzhko, V. V.
    Zvonkov, E. E.
    Vorobyev, A., I
    [J]. TERAPEVTICHESKII ARKHIV, 2007, 79 (07): : 62 - 66
  • [9] Clinical characteristics and prognostic factors in diffuse large B-cell lymphoma with bone marrow involvement.
    Lee, K.
    Yi, J.
    Choi, I.
    Kim, J.
    Kim, D.
    Lee, J.
    Heo, D.
    Bang, Y.
    Cho, H.
    Kim, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 443S - 443S
  • [10] Prognostic impact of bone marrow involvement for patients with diffuse large B-cell lymphoma in the era of rituximab
    Kang, B. W.
    Lee, Y. J.
    Chae, Y. S.
    Moon, J. H.
    Kim, J. G.
    Sohn, S. K.
    Suh, J. S.
    Park, T. I.
    Kim, M. K.
    Hyun, M. S.
    Kim, H. J.
    Lee, J.
    Yang, D. H.
    Bae, S. H.
    Ryoo, H.
    Kwon, K. Y.
    Kim, J. Y.
    Do, Y. R.
    Park, K. U.
    Kim, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)